Neurosurgeon Leads the Way in Eye Tracking Diagnosis for Concussion

From the age of six, Dr. Uzma Samadani, MD, Ph.D, knew she wanted to be a doctor.

Read More →

Oculogica Announces New Category 3 CPT Code Created by American Medical Association

Oculogica, Inc., a pioneer in algorithm-based neuro-diagnostics for brain health, announced today that the American Medical Association (AMA) has confirmed the addition of a new Category 3 CPT Code, 0X17T, Eye movement analysis test without spatial calibration, allowing clinicians to appropriately report the services related exclusively to the Oculogica EyeBOX® exam.

Read More →

FDA: The FDA Recommends Only Using Cleared or Approved Medical Devices to Help Assess or Diagnose a Head Injury, Including Concussion: FDA Safety Communication

Certain products intended to aid in the assessment, diagnosis, or management of a head injury, which includes concussion, traumatic brain injury (TBI), and mild traumatic brain injury (mild TBI or mTBI) are considered medical devices regulated by the FDA.

Read More →

FDA: Medical Devices For Assessing Head Injury

CDRH recognizes that head injury is a major source of concern since the presence and severity of a head injury may not be readily assessable.

Read More →

JAMA: Eye-Tracking Test Approved to Help Diagnose Concussion

A noninvasive test that doesn’t require comparison with a baseline assessment before an injury occurred has received FDA approval to help diagnose concussion in children and adults.

Read More →

Oculogica Issued Patent for Biometric Identification Using an Eye Tracking System

Oculogica, Inc., a pioneer in algorithm-based neuro-diagnostics, announced today that the U.S. Patent and Trademark Office (USPTO) has issued the company a patent for a method of identifying patients using biometric information measured and captured by an eye tracking system. Identification of the patient may be performed by a cloud-based or local biometric service.

Read More →

Oculogica Receives FDA Marketing Authorization for EyeBOX® Device, the First Non-Invasive, Baseline-Free Test for Concussion

FDA Grants Marketing Authorization for Use in Children 5 and Older and Adults up to 67 Years of Age. January 3, 2019 — NEW YORK– …

Read More →

CHOP News: Are Eyes a Window to Diagnosing Acute Concussion in Youth?

There is a growing body of evidence that concussion can impair eye movement. During the past seven years, clinician-scientists at Children’s Hospital of Philadelphia’s (CHOP) Center for Injury Research and Prevention (CIRP) have evaluated the utility of a visio-vestibular exam to detect deficits in concussed pediatric and adolescent patients, and the use of automated eye tracking technology to objectively measure these deficits.

Read More →

MIT Technology Review: Looking Concussion in the Eye

Eye-tracking technology could help take the guesswork out of diagnosing brain injuries.

Read More →

Angel Insights Blog: Oculogica Receives Luis Villalobos Award for Innovation

Allan May, Life Science Angels says, “This is a company that has done everything right.”

Read More →

Recent Blog Posts

New posts coming soon

Scroll to Top